Hair study comparing healthy volunteers and men with hair loss
Part of Skin clinical trials.
This study looks at differences between men with healthy hair and men with male pattern baldness (androgenetic alopecia). It involves collecting samples like blood, hair, and stool to understand hair loss better. If you have hair loss, you may need to stop using certain treatments during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man between 21 and 45 years old
- Have a body mass index (BMI) between 18.5 and 30
- Be willing to give stool, blood, scalp swabs, and hair follicle samples
- If you have hair loss, it must be male pattern baldness at a certain stage (Norwood grade III Vertex to V)
- If you have hair loss, you must be able to take oral minoxidil and stop using other hair loss treatments during the study
- Not have certain health issues like autoimmune disease, diabetes, thyroid problems, severe dandruff, or scalp conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.
This trial tests a new treatment for male pattern baldness (androgenic alopecia). It is for men with a moderate level of hair loss who have not used any hair loss treatments in the last 90 days.
This study looks at a computer-guided system (ARTAS) to move hair follicles to thinning areas to treat male pattern hair loss. You might join if you’re a man with moderate thinning and can follow the study’s hair-cutting and follow-up steps.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
Hear when a new Hair Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.